A detailed history of Regal Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Regal Investment Advisors LLC holds 3,739 shares of AMGN stock, worth $988,928. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,739
Previous 4,171 10.36%
Holding current value
$988,928
Previous $1.3 Million 7.6%
% of portfolio
0.09%
Previous 0.09%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $133,652 - $145,748
-432 Reduced 10.36%
3,739 $1.2 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $16,553 - $20,116
63 Added 1.53%
4,171 $1.3 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $205,147 - $247,639
763 Added 22.81%
4,108 $1.17 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $15,597 - $17,596
-61 Reduced 1.79%
3,345 $963,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $24,488 - $30,403
112 Added 3.4%
3,406 $915,000
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $19,284 - $22,803
90 Added 2.81%
3,294 $731,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $20,321 - $24,768
90 Added 2.89%
3,204 $774,000
Q4 2022

Mar 01, 2023

BUY
$229.03 - $291.01 $6,183 - $7,857
27 Added 0.87%
3,114 $817,000
Q3 2022

Nov 15, 2022

SELL
$224.46 - $253.15 $47,585 - $53,667
-212 Reduced 6.43%
3,087 $696,000
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $111,663 - $124,262
-484 Reduced 12.79%
3,299 $803,000
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $30,697 - $33,959
140 Added 3.84%
3,783 $915,000
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $15,313 - $17,525
77 Added 2.16%
3,643 $820,000
Q3 2021

Nov 05, 2021

BUY
$212.27 - $248.7 $81,723 - $95,749
385 Added 12.1%
3,566 $758,000
Q2 2021

Aug 09, 2021

BUY
$233.58 - $259.14 $743,017 - $824,324
3,181 New
3,181 $775,000
Q1 2021

May 12, 2021

SELL
$221.91 - $258.6 $968,859 - $1.13 Million
-4,366 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $944,715 - $1.12 Million
4,366 New
4,366 $1 Million
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $429,904 - $570,170
-2,359 Closed
0 $0
Q4 2019

Jan 29, 2020

SELL
$189.21 - $243.2 $25,164 - $32,345
-133 Reduced 5.34%
2,359 $569,000
Q3 2019

Nov 15, 2019

SELL
$174.11 - $208.62 $11,839 - $14,186
-68 Reduced 2.66%
2,492 $482,000
Q2 2019

Jul 26, 2019

BUY
$166.7 - $195.41 $89,184 - $104,544
535 Added 26.42%
2,560 $472,000
Q1 2019

May 09, 2019

SELL
$180.87 - $203.88 $23,513 - $26,504
-130 Reduced 6.03%
2,025 $385,000
Q4 2018

Feb 04, 2019

SELL
$178.4 - $208.25 $67,256 - $78,510
-377 Reduced 14.89%
2,155 $419,000
Q3 2018

Nov 05, 2018

BUY
$185.29 - $208.89 $148,973 - $167,947
804 Added 46.53%
2,532 $525,000
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $35,866 - $40,286
-216 Reduced 11.11%
1,728 $319,000
Q1 2018

Apr 25, 2018

SELL
$169.43 - $198.0 $1.91 Million - $2.24 Million
-11,299 Reduced 85.32%
1,944 $331,000
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $29,538 - $33,003
-175 Reduced 1.3%
13,243 $2.3 Million
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $2.24 Million - $2.56 Million
13,418
13,418 $2.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Regal Investment Advisors LLC Portfolio

Follow Regal Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.